Tyson Bertmaring

Adrian Veres, the Chief Scientific Officer and co-founder of Dyno Therapeutics, along with Tyson Bertmaring, Head of Partnership Success, delve into the innovative integration of Agile methodologies in scientific research. They reveal how Dyno uses the Agile Product Operating Model to enhance collaboration and adaptability in gene therapy projects. Key discussions include transforming incentive structures to promote team success and the importance of cross-functional teams in driving breakthrough results. Their insights highlight a culture of continuous improvement and shared goals.